Weekly News Recap #Phispers
Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda’s antipsychotic pill for bipolar disorder, schizophrenia
In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...
Impressions : 945
Royalty Pharma inks US$ 2 bn cancer drug deal with Revolution; Astra-Daiichi’s Datroway wins US approval for lung cancer
In news this week, Royalty Pharma committed up to US$ 2 billion to Revolution Medicines for their promising pancreatic and lung...
Impressions : 3193
Roche announces US$ 50 bn investment in US to avoid tariffs; Regeneron signs US$ 3 bn onshoring deal with Fujifilm
After Eli Lilly, Johnson & Johnson and Novartis, Roche has announced plans to manufacture in the US to avoid tariffs. The Swiss...
Impressions : 1460
FDA panel votes against Intercept’s liver med Ocaliva; Lilly’s Ebglyss wins approval for eczema
Intercept Pharmaceuticals
faced a major setback as a US Food and Drug Administration (FDA) panel voted
against the confirmato...
Impressions : 1204
GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids
GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...
Impressions : 1177
Lilly’s Alzheimer’s drug gets FDA nod; GSK buys rights to mRNA vaccines from Curevac for US$ 1.56 bn
This week, the US Food and Drug Administration (FDA) finally approved Eli Lilly’s Alzheimer’s drug donanemab after ...
Impressions : 1235
Gilead acquires CymaBay for US$ 4.3 billion; Exscientia sacks founder CEO Andrew Hopkins
In this week’s Phispers, Gilead boosted its liver portfolio with the US$ 4.3 billion acquisition of CymaBay Therapeutics....
Impressions : 1924
China to work with EU on aligning API standards; Lupin stumbles with FDA yet again
This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regu...
Impressions : 2229
After sartans, diabetes drug metformin being tested for cancer causing impurities; FDA’s overseas inspections drop
This week in Phispers, we bring you the major announcements made by Sanofi’s new CEO Paul Hudson at its strategy meet.
...
Impressions : 2742
FDA releases GDUFA II fee for FY20; Teva to recover settlement charge from execs
This week, the USFDA released its GDUFA II user fee for fiscal 2020.
Unlike last year, when the fees were hiked significantly...
Impressions : 1676
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.